-
Goldman Sachs Upgrades Arch Capital, Lifts Price Target To $79
Wednesday, September 7, 2016 - 10:16am | 460Read More...Goldman Sachs has upgraded Arch Capital Group Ltd. (NASDAQ: ACGL) to Neutral from Sell, as it is convinced "management is willing to ramp up its sub-scale mortgage operations faster than previously expected" with the acquisition of American International Group Inc (NYSE: AIG)'s United Guaranty...
-
Goldman Sachs Adds AIG To Conviction Buy List
Monday, August 8, 2016 - 8:49am | 354Read More...Goldman Sachs’ Michael Nannizzi believes a combination of macro factors and attributes specific to American International Group Inc (NYSE: AIG) creates an increasingly attractive risk/reward profile for the stock. Nannizzi reiterated a Buy rating on the company, with a price target of $68....
-
Goldman Sachs Reviews AIG's Q1 Miss
Tuesday, May 3, 2016 - 12:48pm | 272Read More...American International Group Inc (NYSE: AIG) reported its 1Q16 results, with the operating EPS well below the estimate and the consensus. Goldman Sachs’ Michael Nannizzi maintains a Buy rating on the company, with a price target of $66. 1Q Results “The headline miss was driven largely...
-
Goldman Sachs Upgrades Property & Casualty Insurance On M&A Upside, Prefers W. R. Berkley To Validus And Arch Capital
Wednesday, July 8, 2015 - 9:27am | 372Read More...In a report published Wednesday, Goldman Sachs analyst Michael Nannizzi raised his Property & Casualty Insurance coverage to "Neutral" from "Cautious" as more M&A transactions are "likely." "M&A is not only a risk, but a function of challenging fundamentals as companies seek M&A as...
-
American Physicians Service Group (AMPH) Maintains Outperform Rating
Tuesday, March 2, 2010 - 10:49am | 106Read More...Oppenheimer analyst Michael Nannizzi maintained his Outperform rating for shares of American Physicians Service Group (Nasdaq: AMPH). The Oppenheimer analyst noted that American Physicians Service Group beat Oppenheimer's estimate for 4th quarter 2009 earnings. Nannizzi went on to say that, "fourth...
-
Investment Income To Support TRV’s Stock Valuation
Tuesday, February 2, 2010 - 11:29am | 159Read More...Analyst Michael Nannizzi of Oppenheimer & Co maintains his "outperform" rating on Travelers Companies (NYSE: TRV), while raising his estimates for the company. The target price for TRV has been raised from $58 to $60. According to Oppenheimer & Co, “Travelers Companies remains positioned...
